5Miltiadis K ,Fabrizio F, Gianluigi 0, et al. Percutaneous Treatmentof Malignant Jaundice Due to Extrahepatic Cholangiocarcinoma:Covered ViabilStent Versus Uncovered Wallstents [J].CardiovascIntervent Radiol,2010, 33(1): 97-106.
7Shaib Y, El-Serag HB .The epidemiology of cholangiocarcinoma[J].Semin Liver Dis, 2004,24(7):115-125.
8Miyakawa S, Ishihara S, Horiguchi A,et al. Biliary tract cancertreatment: results from the Biliary Tract Cancer Statistics Registryfrom 1998 to 2004 in Japan [J].J Hepatobiliary Pancreat Surg,2002,9(5):569-575.
9Rosas-Ballina M, Tracey KJ. Cholinergic control of inflammation[J].J Intern Med ,2009,265(6):663-679.
10Habermehl D, Lindel K, Rieken S, et al. Chemoradiation in pa-tients with unresectable extrahepatic and hilar cholangiocarcinomaor at high risk for disease recurrence after resection : Analysis oftreatment efficacy and failure in patients receiving postoperative orprimary chemoradiation [J].Strahlenther Onkol, 2012,13(6):78-81.
